Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immunotherapy Sciences
Nantes, France
- Ownership
- Private
- Development stage
- Other
01
Overview
OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing first-in-class immunotherapies for cancer and autoimmune diseases. The company's lead asset, Tedopi, is a neoepitope-based cancer vaccine currently in Phase 3 clinical trials for non-small cell lung cancer (NSCLC). OSE also advances a diverse pipeline of monoclonal antibodies and bispecific fusion proteins, including lusvertikimab for ulcerative colitis and various partnered programs with major pharmaceutical firms. Leveraging its proprietary BiCKI platform, the company aims to modulate the immune system to treat severe diseases with high unmet medical needs.
- Therapeutic areas
- OncologyImmunologyNephrologyGastroenterology
- Modalities
- Monoclonal antibodyVaccineBispecific monoclonal antibodyRecombinant fusion protein
- Industry
- Biotech
02
Partnerships
AbbVieBoehringer IngelheimVeloxis PharmaceuticalsServier
Beyond the preview
Go deeper on Immunotherapy Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunotherapy Sciences.